Stock listing

Galectin Therapeutics Inc.

Selected listing: GALT · NASDAQ · USD · US

Galectin Therapeutics Inc. (NASDAQ:GALT), Health Technology. Latest release Oct 6, 2026: Galectin Therapeutics to Present at the American Association…

GALT:NASDAQUSDUSUpdated September 25, 2026

Ticker: NASDAQ:GALT
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: NASDAQ
Currency: USD

About Galectin Therapeutics Inc.

Galectin Therapeutics Inc. is a public company traded under the ticker GALT in the American market. Galectin Therapeutics focuses on developing innovative therapies for fibrotic diseases and cancer.

Latest news from Galectin Therapeutics Inc.

Galectin Therapeutics to Present at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting 2026

October 6, 2026

Galectin Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference

September 10, 2026

Galectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update

August 14, 2026

Galectin Therapeutics Announces Conversion of $105.8 Million in Debt to Equity, Significantly Strengthening Balance Sheet

August 4, 2026

Galectin Therapeutics Announces Positive Type C Meeting with the FDA for Belapectin in Patients with MASH Cirrhosis and Portal Hypertension

June 22, 2026

All Galectin Therapeutics Inc. news →

Research Galectin Therapeutics Inc.

Galectin Therapeutics Inc. company profile

View the public company page for Galectin Therapeutics Inc. on 6ix.

Galectin Therapeutics Inc. news

Read company news and market updates connected to Galectin Therapeutics Inc..

Galectin Therapeutics Inc. investor events

Find investor webinars, events, and replay context for Galectin Therapeutics Inc..